BRAIN Biotech 

€2.6
8
-€0.02-0.76% Thursday 15:30

Statistik

Dagens högsta
-
Dagens lägsta
-
52V högsta
-
52V lägsta
-
Volym
-
Genomsnittlig volym
-
Marknadsvärde
54.62M
P/E förhållande
-
Utdelningsavkastning
-
Utdelning
-

Kommande

Inkomster

15JanFörväntad
Q2 2022
Q4 2022
Q1 2023
Q2 2023
Q4 2023
Q1 2024
Nästa
999
333
-333
-999
Förväntad EPS
Ej tillämpligt
Verklig EPS
Ej tillämpligt

Människor följer också

Den här listan baseras på bevakningslistorna för människor på Stock Events som följer BNN.XETRA. Det är inte en investeringsrekommendation.

Konkurrenter

Denna lista är en analys baserad på nyliga marknadshändelser. Det är inte en investeringsrekommendation.

Om

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
Show more...
VD
Mr. Adriaan Moelker
Anställda
319
Land
DE
ISIN
DE0005203947
WKN
000520394

Noteringar